投稿信-Cover-Letter-和Highlights-模板
模板1
Dear Prof. XXXXX,
Here within enclosed is our paper for consideration to be published on “(Journal name)”. The further information about the paper is in the following:
The Title: XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
The Authors: XXXXXXXXXX XXXXXXXXXXXX and XXXXXXXXXX
The authors claim that none of the material in the paper has been pub lished or is under consideration for publication elsewhere.
I am the corresponding author and my address and other information is as follows,
Address: Department of XXXXXXXXX,
Tsinghua University,
Beijing, 10084,
P.R.China
E-mail:
Tel: 86-10-62785001
Fax: 86-10-62785001
Thank you very much for consideration!
Sincerely Yours,
Dr. XXXXXXXXXXX
模板2
Dear XX (Editor):
Here is our paper submitted to "(XX Journal)".
The Title: XXXX
The Authors: XXX XXX and XXX
In this paper, we ...
The authors claim that none of the material in the paper has been published or is under consideration for publication elsewhere.
The corresponding author is Dr. XXX and his address and other information is as following:
Address: Department of XXX, XX University, ..., P.R.China
E-mail:
Tel: +86-xxx-xxxxxxxx
Fax: +86-xxx-xxxxxxxx
Thank you very much for consideration!
Sincerely Yours,
Dr. xxx
模板3
Dear Mr. **
We believe the paper may be of particular interest to the readers of your journal as it ........
1. The work described has not been submitted elsewhere for publication, in whole or in part, and all the authors listed have approved the manuscript that is enclosed.
2. I have read and have abided by the statement of ethical standards for manuscripts submitted to Neuroscience.
kind regards.
Your sincerely,
通讯作者
Dear Prof. Gil:
This is a manuscript by**and **entitled “.......”. It is submitted to be considered for publication as a “...” in your journal. This paper is new. Neither the entire paper nor any part of its content has been published or has been accepted elsewhere. It is not being submitted to any other journal.
Correspondence should be addressed to **at the following address, phone and fax number, and email address:
...
Thanks very much for your attention to our paper.
Sincerely yours,**
投稿信模版四（实例）
Case 1
Dear Editor,
We would like to submit the enclosed manuscript entitled "GDNF Acutely Modulates Neuronal Excitability and A-type Potassium Channels in Midbrain Dopaminergic Neurons", which we wish to be considered for publication in Nature Neuroscience.
GDNF has long been thought to be a potent neurotrophic factor for the survival of midbrain dopaminergic neurons, which are degenerated in Parkinson’s disease. In this paper, we report an unexpected, acute effect of GDNF on A-type potassium channels, leading to a potentiation of neuronal excitability, in the dopaminergic neurons in culture as well as in adult brain slices. Further, we show that GDNF regulates the K+ channels through a mechanism that involves activation of MAP kinase. Thus, this study has revealed, for the first time, an acute modulation of ion channels by GDNF. Our findings challenge the classic view of GDNF as a long-term survival factor for midbrain dopaminergic neurons, and suggest that the normal function of GDNF is to regulate neuronal excitability, and consequently dopamine release. These results may also have implications in the treatment of Parkinson’s disease.
Due to a direct competition and conflict of interest, we request that Drs. XXX of Harvard Univ., and YY of Yale Univ. not be considered as reviewers. With thanks for your consideration, I am
Sincerely yours,
case2
Dear Editor,
We would like to submit the enclosed manuscript entitled "Ca2+-binding protein frequenin mediates GDNF-induced potentiation of Ca2+ channels and
transmitter release", which we wish to be considered for publication in Neuron.
We believe that two aspects of this manuscript will make it interesting to general readers of Neuron. First, we report that GDNF has a long-term regulatory effect on neurotransmitter release at the neuromuscular synapses. This provides the first physiological evidence for a role of this new family of neurotrophic factors in functional synaptic transmission. Second, we show that the GDNF effect is mediated by enhancing the expression of the Ca2+-binding protein frequenin. Further, GDNF and frequenin facilitate synaptic transmission by enhancing Ca2+ channel activity, leading to an enhancement of Ca2+ influx. Thus, this study has identified, for the first time, a molecular target that mediates the long-term, synaptic action of a neurotrophic factor. Our findings may also have general implications in the cell biology of neurotransmitter release.
Highlights
Highlights are a short collection of bullet points that convey the core findings and provide readers with a quick textual overview of the article. These three to five bullet points
describe the essence of the research (e.g. results or conclusions) and highlight what is distinctive about it.
Highlights will be displayed in online search result lists, the contents list and in the online article, but will not (yet) appear in the article PDF file or print.
Author instructions:
Highlights should be submitted as a separate file in EES by selecting "Highlights" from the
drop-down list when uploading files. Please adhere to the specifications below.
Specifications:
?Include 3 to 5 highlights.
?There should be a maximum of 85 characters, including spaces, per highlight.
?Only the core results of the paper should be covered.
Examples
Journal of Health Economics, Volume 29, Issue 4, July 2010, 524-535
Highlights
?We model two hospitals which have regulated prices and compete on quality.
?We examine changes in the level of information about hospital quality.
?Increasing information will increase quality if hospital costs are similar.
?Increasing information will decrease quality if hospital costs are very different.
?Welfare effects depend on ex-ante or ex-post assumptions about quality information.
Applied Catalysis A, General, Volumes 411-412, 16 January 2012, 7-14 Highlights
?Highly c-axis oriented ZnO nanowires were grown on glass using aqueous solutions.
?The growth temperature does not exceed 95 °C in any step of the synthesis.
?The photocatalytic and wetting properties were studied upon UV irradiation.
?ZnO nanowires show superior photocatalytic activity.
?We report a reversible photo-induced transition from hydrophobic to super-hydrophilic.
Biochimica et Biophysica Acta (BBA), Bioenergetics, Volume 1807, Issue 10, October 2011, 1364-1369
Highlights
? A conformational two-state mechanism for proton pumping complex I is proposed.
?The mechanism relies on stabilization changes of anionic ubiquinone intermediates.
?Electron-transfer and protonation should be strictly controlled during turnover.
?The mechanism explains the full reversibility of complex I.
Learning and Instruction, Volume 21, Issue 6, December 2011, 746-756 Highlights
?Fading of a script alone does not foster domain-general strategy knowledge.
?Performance of the strategy declines during the fading of a script.
?Monitoring by a peer keeps performance of the strategy up during script fading.
?Performance of a strategy after fading fosters domain-general strategy knowledge.
?Fading and monitoring by a peer combined foster domain-general strategy knowledge.
(完整版)英文投稿邮件写作模板
一、最初投稿Cover letter Dear Editors: We would like to submit the enclosed manuscript entitled “Paper Title”, which we wish to be considered for publication in “Journal Name”. No conflict of interest exits in the submission of this manuscript, and manuscript is approved by all authors for publication. I would like to declare on behalf of my co-authors that the work described was original research that has not been published previously, and not under consideration for publication elsewhere, in whole or in part. All the authors listed have approved the manuscript that is enclosed. In this work, we evaluated …… (简要介绍一下论文的创新性). I hope this paper is suitable for “Journal Name”. The following is a list of possible reviewers for your consideration: 1) Name A E-mail: ××××@×××× 2) Name B E-mail: ××××@×××× We deeply appreciate your consideration of our manuscript, and we look forward to receiving comments from the reviewers. If you have any queries, please don’t hesitate to contact me at the address below. Thank you and best regards. Yours sincerely, ×××××× Corresponding author: Name: ××× E-mail: ××××@×××× 二、催稿信 Dear Prof. ×××: Sorry for disturbing you. I am not sure if it is the right time to contact you to inquire about the status of my submitted manuscript titled “Paper Title”. (ID: 文章稿号), although the status of “With Editor” has been lasting for more than two months, since submitted to journal three months ago. I am just wondering that my manuscript has been sent to reviewers or not?
英文论文投稿信Coverletter模板
英文论文投稿信Cover letter模板 qiusuo BY - 2006-1-17 8:59:00 Dear Editor, We would like to submit the enclosed manuscript entitled "GDNF Acutely Modulates Neuronal Excitability and A-type Potassium Channels in Midbrain Dopaminergic Neurons", which we wish to be considered for publication in Nature Neuroscience. GDNF has long been thought to be a potent neurotrophic factor for the survival of midbrain dopaminergic neurons, which are degenerated in Parkinson’s disease. In this paper, we report an unexpected, acute effect of GDNF on A-type potassium channels, leading to a potentiation of neuronal excitability, in the dopaminergic neurons in culture as well as in adult brain slices. Further, we show that GDNF regulates the K+ channels through a mechanism that involves activation of MAP kinase. Thus, this study has revealed, for the first time, an acute modulation of ion channels by GDNF. Our findings challenge the classic view of GDNF as a long-term survival factor for midbrain dopaminergic neurons, and suggest that the normal function of GDNF is to regulate neuronal excitability, and consequently dopamine release. These results may also have implications in the treatment of Parkinson’s disease. Due to a direct competition and conflict of interest, we request that Drs. XXX of Harvard Univ., and YY of Yale Univ. not be considered as reviewers. With thanks for your consideration, I am Sincerely yours, case2 Dear Editor, We would like to submit the enclosed manuscript entitled "Ca2+-binding protein frequenin mediates GDNF-induced potentiation of Ca2+ channels and transmitter release", which we wish to be considered for publication in Neuron. We believe that two aspects of this manuscript will make it interesting to general readers of Neuron. First, we report that GDNF has a long-term regulatory effect on neurotransmitter release at the neuromuscular synapses. This provides the first physiological evidence for a role of this new family of neurotrophic factors in functional synaptic transmission. Second, we show that the GDNF effect is mediated by enhancing the expression of the Ca2+-binding protein frequenin. Further, GDNF and frequenin facilitate synaptic transmission by enhancing Ca2+ channel activity, leading to an enhancement of Ca2+ influx. Thus, this study has identified, for the first time, a molecular target that mediates the long-term, synaptic action of a
投稿的信件书写方法
一、投稿信 1. Dear Dr. Defendi ML: I am sending a manuscript entitled “” by – which I should like to submit for possible publication in the journal of - . Yours sincerely 2. Dear Dr. A: Enclosed is a manuscript entitled “” by sb, which we are submitting for pub lication in the journal of - . We have chosen this journal because it deals with - . We believe that sth would be of interest to the journal’s readers. 3. Dear Dr. A: Please find enclosed for your review an original research article, “” by sb. All authors have read and approve this version of the article, and due care has been taken to ensure the integrity of the work. No part of this paper has published or submitted elsewhere. No conflict of interest exits in the submission of this manuscript, and we have attached to this letter the signed letter granting us permission to use Figure 1 from another source. We appreciate your consideration of our manuscript, and we look forward to receiving comments from the reviewers. 二、询问有无收到稿件 Dear Editors, We dispatched our manuscript to your journal on 3 August 2006 but have not, as yet, receive acknowledgement of their safe arrival. We fear that may have been lost and should be grateful if you would let us know whether or not you have received them. If not, we will send our manuscript again. Thank you in advance for your help. 三、询问论文审查回音 Dear Editors， It is more than 12 weeks since I submitted our manuscript (No: ) for possible publication in your journal. I have not yet received a reply and am wondering whether you have reached a decision. I should appreciated your letting me know what you have decided as soon as possible. 四、关于论文的总体审查意见 1. This is a carefully done study and the findings are of considerable interest. A few minor revision are list below. 2. This is a well-written paper containing interesting results which merit publication. For the benefit of the reader, however, a number of points need clarifying and certain statements require further justification. There are given below. 3. Although these observation are interesting, they are rather limited and do not advance our knowledge of the subject sufficiently to warrant publication in PNAS. We suggest that the authors try submitting their findings to specialist journal such as – 4. Although this paper is good, it would be ever better if some extra data were added. 5. This manuscript is not suitable for publication in the journal of –because the main observation it describe was reported 3 years ago in a reputable journal of - . 6. Please ask someone familiar with English language to help you rewrite this paper. As you will see, I have made some correction at the beginning of the paper where some syntax is not satisfactory. 7. We feel that this potentially interesting study has been marred by an inability to communicate the finding correctly in English and should like to suggest that the authors seek the advice of someone with a
SCI 投稿Cover letter模板大全
SCI 投稿Cover letter模板大全 1. 第一次投稿Cover letter：主要任务是介绍文章主要创新以及声 明没有一稿多投 Dear Editors: We would like to submit the enclosed manuscript entitled “Paper Title”, which we wish to be considered for publication in “Journal Name”. No conflict of interest exits in the submission of this manuscript, and manuscript is approved by all authors for publication. I would like to declare on behalf of my co-authors that the work described was original research that has not been published previously, and not under consideration for publication elsewhere, in whole or in part. All the authors listed have approved the manuscript that is enclosed. In this work, we evaluated …… (简要介绍一下论文的创新性). I hope this paper is suitable for “Journal Name”. The following is a list of possible reviewers for your consideration: 1) Name A E-mail: ××××@×××× 2) Name B E-mail: ××××@×××× We deeply appreciate your consideration of our manuscript, and we look forward to receiving comments from the reviewers. If you have any queries, please don’t hesitate to contact me at the address below. Thank you and best regards. Yours sincerely, ××××××Corresponding author: Name: ××× E-mail: ××××@×××× 2. 催稿信：询问稿件处理到声明步骤 Dear Prof. ×××: Sorry for disturbing you. I am not sure if it is the right time to contact you to inquire about the status of my submitted manuscript titled “Paper Title”. (ID: 文章稿号), although the status of “With Editor” has been lasting for more than two months, since submitted to journal three months ago. I am just wondering that my manuscript
英文论文投稿邮件标准格式
Sample cover letter [Your Name] [Your Affiliation] [Your Address] [Date] Dear [Editor name], I/We wish to submit an original research article entitled “[title of article]” for consideration by [journal name]. I/We confirm that this work is original and has not been published elsewhere, nor is it currently under consideration for publication elsewhere. In this paper, I/we report on / show that _______. This is significant because __________. We believe that this manuscript is appropriate for publication by [journal name]because it… [specific re ference to the journal’s Aims & S cope]. __________. [Please explain in your own words the significance and novelty of the work, the problem that is being addressed, and why the manuscript belongs in this journal. Do not simply insert your abstract into your cover letter! Briefly describe the research you are reporting in your paper, why it is important, and why you think the readership of the journal would be interested in it.] We have no conflicts of interest to disclose. If you feel that the manuscript is appropriate for your journal, we suggest the following reviewers: [List reviewers and contact info, if requested by the journal] Please address all correspondence concerning this manuscript to me at [email address]. Thank you for your consideration of this manuscript. Sincerely, [Your name]
JMCA投稿模板
Please do not adjust margins Please do not adjust margins Address here. Address here. Address here. ? Footnotes relating to the title and/or authors should appear here. Electronic Supplementary Information (ESI) available: [details of any supplementary information available should be included here]. See DOI: 10.1039/x0xx00000x Received 00th January 20xx, Accepted 00th January 20xx DOI: 10.1039/x0xx00000x Title Author Full Name,*a Author Full Name b and Author Full Name c Abstract text goes here. The abstract should be a single paragraph that summarises the content of the article A Headings are the primary heading type e.g. Introduction, Results and discussion, Experimental B Headings should always be subordinate to A headings e.g. Synthetic procedures, Materials and methods, Crystallography. C headings should always be subordinate to B headings e.g. General procedure for synthesis of compound X. The main paragraph text follows directly on here. The main text of the article should appear here with headings as appropriate. Conclusions The conclusions section should come in this section at the end of the article, before the acknowledgements. Conflicts of interest In accordance with our policy on Conflicts of interest please ensure that a conflicts of interest statement is included in your manuscript here. Please note that this statement is required for all submitted manuscripts. If no conflicts exist, please state that “There are no conflicts to declare”. Acknowledgements The acknowledgements come at the end of an article after the conclusions and before the notes and references. Notes and references ? Footnotes relating to the main text should appear here. These might include comments relevant to but not central to the matter under discussion, limited experimental and spectral data, and crystallographic data. § §§ etc. Citations should appear here in the format A. Name, B. Name and C. Name, Journal Title , 2000, 35, 3523; A. Name, B. Name and C. Name, Journal Title , 2000, 35, 3523. …
投稿信coverletter和highlights模板
模板1 Dear Prof. XXXXX, Here within enclosed is our paper for consideration to be published on “(Journal name)”. The further information about the paper is in the following: The Title: XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX The Authors: XXXXXXXXXX XXXXXXXXXXXX and XXXXXXXXXX The authors claim that none of the material in the paper has been pub lished or is under consideration for publication elsewhere. I am the corresponding author and my address and other information is as follows,
Address: Department of XXXXXXXXX, Tsingh ua University, Beijin g, 10084, E-mail: Tel: 86- Fax: 86- Thank you very much for consideration! Sincerely Yours, Dr. XXXXXXXXXXX
模板2 Dear XX (Editor): Here is our paper submitted to "(XX Journal)". The Title: XXXX The Authors: XXX XXX and XXX In this paper, we ... The authors claim that none of the material in the paper has been published or is under consideration for publication elsewhere. The corresponding author is Dr. XXX and his address and other information is as following: Address: Department of XXX, XX University, ..., Tel: +86-xxx-xxxxxxxx
英文论文投稿信Cover letter 模板
英文论文投稿信Cover?letter模板 qiusuo BY - 2006-1-17 8:59:00 Dear Editor, We would like to submit the enclosed manuscript entitled "GDNF Acutely Modulates Neuronal Excitability and A-type Potassium Channels in Midbrain Dopaminergic Neurons", which we wish to be considered for publication in Nature Neuroscience. GDNF has long been thought to be a potent neurotrophic factor for the survival of midbrain dopaminergic neurons, which are degenerated in Parkinson’s disease. In this paper, we report an unexpected, acute effect of GDNF on A-type potassium channels, leading to a potentiation of neuronal excitability, in the dopaminergic neurons in culture as well as in adult brain slices. Further, we show that GDNF regulates the K+ channels through a mechanism that involves activation of MAP kinase. Thus, this study has revealed, for the first time, an acute modulation of ion channels by GDNF. Our findings challenge the classic view of GDNF as a long-term survival factor for midbrain dopaminergic neurons, and suggest that the normal function of GDNF is to regulate neuronal excitability, and consequently dopamine release. These results may also have implications in the treatment of Parkinson’s disease. Due to a direct competition and conflict of interest, we request that Drs. XXX of Harvard Univ., and YY of Yale Univ. not be considered as reviewers. With thanks for your consideration, I am Sincerely yours, case2 Dear Editor, We would like to submit the enclosed manuscript entitled "Ca2+-binding protein frequenin mediates GDNF-induced potentiation of Ca2+ channels and transmitter release", which we wish to be considered for publication in Neuron. We believe that two aspects of this manuscript will make it interesting to general readers of Neuron. First, we report that GDNF has a long-term regulatory effect on neurotransmitter release at the neuromuscular synapses. This provides the first physiological evidence for a role of this new family of neurotrophic factors in functional synaptic transmission. Second, we show that the GDNF effect is mediated by enhancing the expression of the Ca2+-binding protein frequenin. Further, GDNF and frequenin facilitate synaptic transmission by enhancing Ca2+ channel activity, leading to an enhancement of Ca2+ influx. Thus, this study has identified, for the first time, a molecular target that mediates the long-term, synaptic action of a neurotrophic factor. Our findings may also have general implications in the cell biology of neurotransmitter release. [0630][投稿写作]某杂志给出的标准Sample Cover Letter[the example used is the IJEB]
投稿coverletter写法
Case 1 Dear Editor, We would like to submit the enclosed manuscript entitled "GDNF Acutely Modulates Neuronal Excitability and A-type Potassium Channels in Midbrain Dopaminergic Neurons", which we wish to be considered for publication in Nature Neuroscience. GDNF has long been thought to be a potent neurotrophic factor for the survival of midbrain dopaminergic neurons, which are degenerated in Parkinson’s disease. In this paper, we report an unexpected, acute effect of GDNF on A-type potassium channels, leading to a potentiation of neuronal excitability, in the dopaminergic neurons in culture as well as in adult brain slices. Further, we show that GDNF regulates the K+ channels through a mechanism that involves activation of MAP kinase. Thus, this study has revealed, for the first time, an acute modulation of ion channels by GDNF. Our findings challenge the classic view of GDNF as a long-term survival factor for midbrain dopaminergic neurons, and suggest that the normal function of GDNF is to regulate neuronal excitability, and consequently dopamine release. These results may also have implications in the treatment of Parkinson’s disease. Due to a direct competition and conflict of interest, we request that Drs. XXX of Harvard Univ., and YY of Yale Univ. not be considered as reviewers. With thanks for your consideration, I am Sincerely yours, case2 Dear Editor, We would like to submit the enclosed manuscript entitled "Ca2+-binding protein frequenin mediates GDNF-induced potentiation of Ca2+ channels and transmitter release", which we wish to be considered for publication in Neuron. We believe that two aspects of this manuscript will make it interesting to general readers of Neuron. First, we report that GDNF has a long-term regulatory effect on neurotransmitter release at the neuromuscular synapses. This provides the first physiological evidence for a role of this new family of neurotrophic factors in functional synaptic transmission. Second, we show that the GDNF effect is mediated by enhancing the expression of the Ca2+-binding protein frequenin. Further, GDNF and frequenin facilitate synaptic transmission by enhancing Ca2+ channel activity, leading to an enhancement of Ca2+ influx. Thus, this study has identified, for the first time, a molecular target that mediates the long-term, synaptic action of a neurotrophic factor. Our findings may also have general implications in the cell biology of neurotransmitter release. 某杂志给出的标准Sample Cover Letter Case 3 Sample Cover Letter Dear Editor of the : Enclosed is a paper, entitled "Mobile Agents for Network Management." Please accept it as a candidate for publication in the . Below are our responses to your submission requirements. 1. Title and the central theme of the article. Paper title: "Mobile Agents for Network Management." This study reviews the concepts of mobile agents and distributed network management system. It proposes a mobile agent-based implementation framework and creates a prototype system to demonstrate the superior performance of a mobile agent-based network over the conventional client-server architecture in a large network environment.